Seminars in Nephrology
Volume 29, Issue 5 , Pages 524-532 , September 2009

Economic Evaluation of Dialysis Therapies

  • Scott Klarenbach, MD, MSc

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
    • Institute of Health Economics, Edmonton, Alberta, Canada
    • Corresponding Author InformationAddress reprint requests to Scott Klarenbach, MD, MSc, Department of Medicine, Division of Nephrology, University of Alberta, 11-107 Clinical Sciences Building, 8440-112 St, Edmonton, Alberta, T6G 2G3 Canada
    • ,
  • Braden Manns, MD, MSc

      Affiliations

    • Institute of Health Economics, Edmonton, Alberta, Canada
    • Department of Medicine, Division of Nephrology, University of Calgary, Calgary, Canada
    • Department of Community Health Sciences, University of Calgary, Calgary, Canada

References 

  1. Lockridge RSJ. The direction of end-stage renal disease reimbursement in the United States. Semin Dial. 2004;17:125–130
  2. Rettig RA, Levinsky NG. Kidney failure and the federal government. Washington DC: National Academy Press; 1991;
  3. Klarman HE, Francis JO, Rosenthal GD. Cost effectiveness analysis applied to the treatment of chronic renal disease. Med Care. 1968;6:48–54
  4. Manns BJ, Mendelssohn DC, Taub KJ. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care. Int J Health Care Finance Econ. 2007;7:149–169
  5. Hirth R. The organization and financing of kidney dialysis and transplant care in the United States of America. Int J Health Care Finance Econ. 2007;7:301–318
  6. Rettig RA. The social contract and the treatment of permanent kidney failure. JAMA. 1996;275:1123–1126
  7. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. U.S. Renal Data System, USRDS 2002 annual data report: atlas of end-stage renal disease in the United States. 2002;
  8. Garella S. The costs of dialysis in the USA. Nephrol Dial Transplant. 1997;12(Suppl 1):10–21
  9. Tomson CR. Recent advances: nephrology. BMJ. 2000;320:98–101
  10. Mallick NP. The costs of renal services in Britain. Nephrol Dial Transplant. 1997;12(Suppl 1):25–28
  11. US Census Bureau. Historical national population estimates. 2000;
  12. Canadian Organ Replacement Register. Preliminary report for dialysis and transplantation 2008. Ottawa: Canadian Institute for Health Information; 2008;
  13. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235–242
  14. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002;22:417–430
  15. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13(Suppl 1):S37–S40
  16. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20:2587–2593
  17. Donaldson C, Shackley P. Economic evaluation. In:  Detels R,  Holland WW,  McEwan J, et al. editor. Oxford textbook of public health. 3rd ed.. Oxford: Oxford University Press; 1997;p. 849–870
  18. Gerard K, Mooney G. QALY league tables: handle with care. Health Econ. 1993;2:59–64
  19. Mauskopf J, Rutten F, Schonfeld W. Cost-effectiveness league tables: valuable guidance for decision makers?. Pharmacoeconomics. 2003;21:991–1000
  20. Drummond MF. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997;
  21. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40:611–622
  22. Goeree R, Manalich J, Grootendorst P, Beecroft ML, Churchill DN. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med. 1995;18:455–464
  23. Neil N, Walker DR, Sesso R, Blackburn JC, Tschosik EA, Sciaraffia V, et al. Gaining efficiencies: resources and demand for dialysis around the globe. Value Health. 2009;12:73–79
  24. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int. 2002;62:2216–2222
  25. Kroeker A, Clark WF, Heidenheim AP, Kuenzig L, Leitch R, Meyette M, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis. 2003;42:49–55
  26. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis. 2001;37:777–789
  27. Agar JW, Knight RJ, Simmonds RE, Boddington JM, Waldron CM, Somerville CA. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis. Nephrology (Carlton). 2005;10:557–570
  28. Komenda P, Levin A, Manns B. The economics of home nocturnal hemodialysis: how should we cost the benefits?. Clin Nephrol. 2007;68:151–158
  29. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial. 2004;17:118–124
  30. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 2003;64:2222–2228
  31. Schaubel DE, Morrison HI, Fenton SS. Comparing mortality rates on CAPD/CCPD and hemodialysis (The Canadian experience: fact or fiction?). Perit Dial Int. 1998;18:478–484
  32. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med. 2005;143:174–183
  33. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334–342
  34. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9:267–276
  35. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:177–183
  36. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999;34:1065–1074
  37. Kjellstrand CM, Evans RL, Petersen RJ, Shideman JR, von Hartitzsch B, Buselmeier TJ. The “unphysiology” of dialysis: a major cause of dialysis side effects?. Kidney Int Suppl. 1975;2:30–34
  38. Kjellstrand CM, Rosa AA, Shideman JR, Rodrigo F, Davin T, Lynch RE. Optimal dialysis frequency and duration: the “unphysiology hypothesis.”. Kidney Int Suppl. 1978;8:S120–S124
  39. Williams AW, Chebrolu SB, Ing TS, Ting G, Blagg CR, Twardowski ZJ, et al. Early clinical, quality-of-life, and biochemical changes of “daily hemodialysis” (6 dialyses per week). Am J Kidney Dis. 2004;43:90–102
  40. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant. 2002;17:1518–1521
  41. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61:2235–2239
  42. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis. 2003;42:13–17
  43. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int. 2003;64:1004–1011
  44. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003;42:36–41
  45. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 2005;67:1500–1508
  46. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298:1291–1299
  47. Manns B, Walsh M, Culleton B, Hemmelgarn B, Tonelli M, Schorr M, et al. The effects of nocturnal hemodialysis compared to conventional hemodialysis on quality of life: a randomized controlled trial. Kidney Int. 2009;75:542–549
  48. Lee CP, Zenios SA, Chertow GM. Cost-effectiveness of frequent in-center hemodialysis. J Am Soc Nephrol. 2008;19:1792–1797
  49. Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int. 2007;27:142–148
  50. U.S. Renal Data Systems. USRDS 2008 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;[cited 2008 Dec 18] http://www.census.gov/popest/archives/1990s/popclockest.txt
  51. de Wit GA, Ramsteijn PG, de Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy. 1998;44:215–232
  52. Medical Professionalism Project: ABIM Foundation. Medical professionalism in the new millennium: a physicians' charter. Lancet. 2002;359:520–522

 Supported by a Scholarship Award from the Kidney Foundation of Canada, and a Population Health Investigator Award from the Alberta Heritage Foundation for Medical Research (S.K.); and supported by a Canadian Institutes of Health Research New Investigator Award (B.M.).

PII: S0270-9295(09)00104-1

doi: 10.1016/j.semnephrol.2009.06.009

Seminars in Nephrology
Volume 29, Issue 5 , Pages 524-532 , September 2009

Article Tools

* Image Usage & Resolution